Wilbur Ellis and Plant Health Care discussion

RNS Number : 5096V
Plant Health Care PLC
15 December 2021
 

RNS

15 December 2021

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Investor Presentation - Wilbur Ellis and Plant Health Care discuss US market opportunities

 

Plant Health Care®(AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that Dr. Christopher Richards, CEO of Plant Health Care, plc and Scott Addy, Vice President of Branded Technologies and Biological Solutions of Wilbur Ellis, will provide a live presentation to discuss the market opportunities for Harpin and PREtec in the USA via the Investor Meet Company platform on 18th January 2022 at 3:30pm GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Plant Health Care plc via: 

https://www.investormeetcompany.com/plant-health-care-plc/register-investor  

Investors who already follow Plant Health Care PLC on the Investor Meet Company platform will automatically be invited.

Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base. Investors who already follow Plant Health Care plc on the Investor Meet Company platform will automatically be invited.

 

For further information, please contact:

Plant Health Care plc

Chris Richards, CEO,     Tel: +1 919 926 1600

 

Arden Partners plc - Nomad & Broker

John Llewellyn-Lloyd / Antonio Bossi   Tel: +44 (0) 20 7614 5900

 

Company website:  www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKNBNCBDDDBD
UK 100

Latest directors dealings